Komori
Earnings9267Genky DrugStores Co.,Ltd.Retail

Financial Results for the Fiscal Year Ending June 2026 (Japanese GAAP) (Consolidated)

For the fiscal year ended June 2026, revenue increased 9.9% year on year and operating profit rose 13.7%, resulting in growth in both revenue and profit. For the fiscal year ending June 2027, the company expects higher revenue and profit, based on plans including 75 new store openings.

Worth reading
31Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
9.9
%
Wording
Conditional
How definitive the wording is.

Results for this period

Full year21 June 2025 to 20 June 2026ConsolidatedJapanese GAAP
Net Sales220,638¥ millionYear on year +9.9%Progress 90.4%
Operating profit10,985¥ millionYear on year +13.7%Progress 91.5%
Ordinary income11,157¥ millionYear on year +12.7%Progress 92.2%
Net income attributable to owners of the parent7,875¥ millionYear on year +11.4%Progress 96.0%

The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.

Net income per share¥258.51
Operating Margin5.0%
Financial position at period-end
Total assets145,598¥ million
of which net assets 61,373 ¥ millionEquity ratio 42.0%vs. prior year-end +0.2pt

塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.

Cash inflows and outflows
Operating+16,975
Investment-20,278
Financials+4,947
Net change+1,644

Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.

Cash and cash equivalents at end of period¥7,866 million
Outlook and shareholder returns
Full-year earnings forecast
Net Sales¥244,000 million (YoY +10.6%)
Operating profit¥12,000 million (YoY +9.2%)
Ordinary income¥12,100 million (YoY +8.4%)
Net income¥8,200 million (YoY +4.1%)
Annual Dividend Forecast13 Yen per share → 13 Yen per share(0.0%)
Payout ratio5.0% actual for the fiscal year ended June 2026; 4.8% forecast for the fiscal year ending June 2027
Factors Behind Changes in Business Performance

Development of dominant market areas through concentrated store openings, opening of 57 new stores, closing of 3 large-format stores, and conversion of 8 stores to the R format. For the next fiscal year, the company plans to pursue EDLP and low-cost operations, strengthen its product lineup, including private-label products and fresh foods, and open 75 new stores.

Disclosure regarding the going concern assumption

No applicable matters

Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 No見積りの変更 No修正再表示 No
Changes in the scope of consolidationNew 0 companies / Excluded 0 companies / Company name None
Material subsequent eventsNo applicable matters.
Impairment loss¥0 million
Breakdown of extraordinary income (loss)Extraordinary income Gain on reversal of subscription rights to shares ¥4 million / Extraordinary loss Loss on disposal and sale of non-current assets ¥9 million
Depreciation and amortization¥7,133 million
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingAvailable (for institutional investors and analysts)
Issued Shares at Period-End31,038,968 shares
Treasury Shares at Period-End532,069 shares
Results for this period
ItemDetails
Fiscal Period ClassificationFull year
Accounting standardsJapanese GAAP
Consolidated / non-consolidatedConsolidated
Period Covered21 June 2025 to 20 June 2026
Net Sales¥220,638 million (YoY +9.9%)
Operating profit¥10,985 million (YoY +13.7%)
Ordinary income¥11,157 million (YoY +12.7%)
Profit attributable to owners of the parent¥7,875 million (YoY +11.4%)
Net income per share¥258.51
Operating Margin5.0%
Equity ratioEnd of the current fiscal period 42.0% / End of previous period 41.8%
Total assets¥145,598 million
Net assets¥61,373 million
Cash flows from operating activities¥16,975 million
Cash flows from investing activities¥-20,278 million
Cash flows from financing activities¥4,947 million
Cash and cash equivalents at end of period¥7,866 million
Full-year earnings forecastNet Sales ¥244,000 million (YoY +10.6%) / Operating profit ¥12,000 million (YoY +9.2%) / Ordinary income ¥12,100 million (YoY +8.4%) / Net income ¥8,200 million (YoY +4.1%)
Annual Dividend Forecast13 Yen per share → 13 Yen per share(0.0%)
Payout ratio5.0% actual for the fiscal year ended June 2026; 4.8% forecast for the fiscal year ending June 2027
Depreciation and amortization¥7,133 million
Impairment loss¥0 million
Breakdown of extraordinary income (loss)Extraordinary income Gain on reversal of subscription rights to shares ¥4 million / Extraordinary loss Loss on disposal and sale of non-current assets ¥9 million
Disclosure regarding the going concern assumptionNo applicable matters
Change in accounting policyChanges due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No
Changes in the scope of consolidationNew 0 companies / Excluded 0 companies / Company name None
Material subsequent eventsNo applicable matters.
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingAvailable (for institutional investors and analysts)
Issued Shares at Period-End31,038,968 shares
Treasury Shares at Period-End532,069 shares
Factors Behind Changes in Business PerformanceDevelopment of dominant market areas through concentrated store openings, opening of 57 new stores, closing of 3 large-format stores, and conversion of 8 stores to the R format. For the next fiscal year, the company plans to pursue EDLP and low-cost operations, strengthen its product lineup, including private-label products and fresh foods, and open 75 new stores.
Items this document does not state (6)
Revision to Earnings ForecastShareholder Return PolicySegment revenueSegment profitRegional salesOrders received and order backlog

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The company advanced the development of dominant market areas through concentrated store openings, opening 57 new stores, closing 3 large-format stores, and converting 8 stores to the R format. For the next fiscal year, it plans to pursue EDLP and low-cost operations, strengthen its product lineup, including private-label products and fresh foods, and open 75 new stores.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Financial Results for the Fiscal Year Ending June 2026 (Japanese GAAP) (Consolidated) | Genky DrugStores Co.,Ltd. (9267) timely disclosure | Komori